The Palatinus Lab focuses on mechanisms leading to disease progression in arrhythmogenic cardiomyopathy. Dr. Palatinus practices at Intermountain Cardiac ICUs
So Happy to See My Teachable Moment published in Journal of Cardiac Failure Intersections highlighting CIED reprogramming in patients with shock.
https://t.co/qTFVYtGG0P
Really proud of our graduate students Steven Valdez and Lindsey Taylor whose manuscript was just published in Circulation Heart Failure!
https://t.co/1oQViQOUv9
Congrats to Lindsey Taylor, 1st year graduate student in the Palatinus Lab who received 3rd place podium presentation at the International Gap Junction Conference for our work on GJA1 20k in response to Mechanical unloading in ACM.
@rbganatra@mvronan I'm so glad this is published!, Ever since residency I have been preaching the benefits of Phenobarbital for AWS. Its nice to see this match my experience. Great work!
Really excited about the prospect of of Intramuscular Epinephrine for out of hospital cardiac arrest. Especially if iv access can't be obtained quickly See the manuscript in the journal Resuscitation. https://t.co/bBDtM87mfn
@NephroNinja@askrenal During my hypertension days working with the late, great Ron Victor, he would do the CT and AVS for anyone that would be a surgical candidate. We saw several patients together who wouldn't want surgery and would leave them on spironolactone though.
@rbganatra the booster (at least the previous one) generated a more robust immune response than infection(https://t.co/H8gv1DjFzo.) But whether it matters, especially if you are under 65 y/o is questionable. I think the elderly should get it. I wish more focus was on boosting ppl >70-80y/o.